identified and validated the clinical value of a 7-AABs panel (p53, PGP9.5, SOX2, CAGE7, GBU4-5, MAGEA1, and CAGE) for the early detection of lung cancer patients in Chinese populations (14). This evidence concerns the gene TP53 and lung carcinoma.